TOP TIERMARKET NEWSWIRE
SEC Form 4 history

BRIDGEBIO PHARMA INC (BBIO) insider trades

BRIDGEBIO PHARMA INC (BBIO) insider trading activity (SEC Form 4). Over the trailing 90 days, BBIO insiders filed 0 purchases totalling $0 and 11 sales totalling $38.0M — net SELLING of $38.0M. Most recent filing: Aug 3, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
11
$38.0M
Net (90d)
-$38.0M
net selling
Most recent
Aug 3, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 3, 2026Apuli MaricelChief Accounting OfficerS Sale—$80.06$160Kfiling
Jul 13, 2026Ellis AndreaDirS SaleOE—$84.00$1.4Mfiling
Jul 13, 2026Cook Jennifer E.DirS SaleOE—$88.54$13.2Mfiling
Jun 24, 2026Cook Jennifer E.DirS SaleOE—$69.92$2.8Mfiling
Jun 24, 2026Valantine HannahDirS SaleOE—$68.25$342Kfiling
Jun 17, 2026Cook Jennifer E.DirS SaleOE—$66.62$6.0Mfiling
Jun 8, 2026Kumar NeilCEOS Sale—$67.67$5.4Mfiling
May 26, 2026Kumar NeilCEOS Sale—$69.44$1.8Mfiling
May 19, 2026Trimarchi ThomasPres, CFOS Sale—$65.08$888Kfiling
May 19, 2026Scott Randal W.DirS SaleOE—$67.15$671Kfiling
May 11, 2026Kumar NeilCEOS Sale—$67.40$5.4Mfiling